News & Updates

Treatment with upadacitinib improves disease activity, pain, function, and quality of life (QoL) in patients with non-radiographic axial spondyloarthritis (nr-axSpA) in a study touted as the first to evaluate a Janus kinase (JAK) inhibitor for this condition.

The monoclonal antibody sarilumab demonstrated significant efficacy in individuals with relapsing polymyalgia rheumatica (PMR), findings from the phase III SAPHYR trial have shown.

Out-of-hospital cardiac arrest (OHCA) tend to occur at a higher rate among patients with rheumatoid arthritis (RA), and this risk increase is especially pronounced in women but not observed in men, a study has found.

Impaired fibrinolysis appears to play a role in underlying digital vasculopathy and its progression in systemic sclerosis (SSc), suggests a study.

In the postintervention results of the VITAL* trial, vitamin D and marine omega-3 fatty acids (n-3 FAs) continued to demonstrate a protective effect against autoimmune diseases in older adults.

In patients with gout and end-stage renal disease (ESRD), haemodialysis appears to have an additional benefit of lowering uric acid (UA) levels, a study has found.